Bluetongue vaccines


Noad, R; Roy, P; (2009) Bluetongue vaccines. Vaccine, 27. D86-D89. ISSN 0264-410X DOI: 10.1016/j.vaccine.2009.08.037

Full text not available from this repository. (Request a copy)

Abstract

Once thought largely restricted to India and Africa, the insect-borne livestock pathogen Bluetongue virus is now present on every continent with the exception of Antarctica. Outbreaks of the disease caused by the virus in Europe over the last decade, and the resulting impact on trade and agriculture, have focussed attention on the production of safe and effective vaccines. The determinants of protection for bluetongue are well defined but the variability of the virus, which exists as 24 immunologically distinct serotypes, means that even regions where large numbers of animals have been vaccinated remain at risk from new outbreaks of the virus. (C) 2009 Elsevier Ltd. All rights reserved.

Item Type: Article
Keywords: Bluetongue, Vaccine, Reverse genetics, virus-like particles, west-nile-virus, protection, sheep, challenge, efficacy, disease, recovery, expression, history
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology
Research Centre: Vaccine Centre
PubMed ID: 19837295
Web of Science ID: 271876100018
URI: http://researchonline.lshtm.ac.uk/id/eprint/4414

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
289Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item